Cargando…
Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy
We evaluated SARS-CoV-2 antibody response in voluntary blood donors in Italy at different timepoints. Immediately after lockdown easing, 908/25,657 donors (3.5%) had low IgG titers against nucleocapsid. In the next 2 years, titers increased despite few COVID-19 symptoms. On multivariate analysis, al...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310387/ https://www.ncbi.nlm.nih.gov/pubmed/37253276 http://dx.doi.org/10.3201/eid2907.221745 |
_version_ | 1785066528738115584 |
---|---|
author | Ferrari, Martina Di Marco, Lorenza Pivetti, Alessandra Paduano, Stefania Vecchi, Chiara Bernabucci, Veronica Critelli, Rosina Maria Lasagni, Simone De Maria, Monica Venturelli, Donatella Pecorari, Monica Boaretto, Giorgia Serpini, Giulia Fregni Romagnoli, Dante Mantovani, Roberto Ceccherelli, Giovanni Battista Villa, Erica |
author_facet | Ferrari, Martina Di Marco, Lorenza Pivetti, Alessandra Paduano, Stefania Vecchi, Chiara Bernabucci, Veronica Critelli, Rosina Maria Lasagni, Simone De Maria, Monica Venturelli, Donatella Pecorari, Monica Boaretto, Giorgia Serpini, Giulia Fregni Romagnoli, Dante Mantovani, Roberto Ceccherelli, Giovanni Battista Villa, Erica |
author_sort | Ferrari, Martina |
collection | PubMed |
description | We evaluated SARS-CoV-2 antibody response in voluntary blood donors in Italy at different timepoints. Immediately after lockdown easing, 908/25,657 donors (3.5%) had low IgG titers against nucleocapsid. In the next 2 years, titers increased despite few COVID-19 symptoms. On multivariate analysis, allergic rhinitis was associated with reduced risk for symptomatic COVID-19. |
format | Online Article Text |
id | pubmed-10310387 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-103103872023-07-01 Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy Ferrari, Martina Di Marco, Lorenza Pivetti, Alessandra Paduano, Stefania Vecchi, Chiara Bernabucci, Veronica Critelli, Rosina Maria Lasagni, Simone De Maria, Monica Venturelli, Donatella Pecorari, Monica Boaretto, Giorgia Serpini, Giulia Fregni Romagnoli, Dante Mantovani, Roberto Ceccherelli, Giovanni Battista Villa, Erica Emerg Infect Dis Research Letter We evaluated SARS-CoV-2 antibody response in voluntary blood donors in Italy at different timepoints. Immediately after lockdown easing, 908/25,657 donors (3.5%) had low IgG titers against nucleocapsid. In the next 2 years, titers increased despite few COVID-19 symptoms. On multivariate analysis, allergic rhinitis was associated with reduced risk for symptomatic COVID-19. Centers for Disease Control and Prevention 2023-07 /pmc/articles/PMC10310387/ /pubmed/37253276 http://dx.doi.org/10.3201/eid2907.221745 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Letter Ferrari, Martina Di Marco, Lorenza Pivetti, Alessandra Paduano, Stefania Vecchi, Chiara Bernabucci, Veronica Critelli, Rosina Maria Lasagni, Simone De Maria, Monica Venturelli, Donatella Pecorari, Monica Boaretto, Giorgia Serpini, Giulia Fregni Romagnoli, Dante Mantovani, Roberto Ceccherelli, Giovanni Battista Villa, Erica Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy |
title | Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy |
title_full | Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy |
title_fullStr | Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy |
title_full_unstemmed | Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy |
title_short | Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy |
title_sort | long-term sars-cov-2 antibody seroprevalence in blood donors, italy |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310387/ https://www.ncbi.nlm.nih.gov/pubmed/37253276 http://dx.doi.org/10.3201/eid2907.221745 |
work_keys_str_mv | AT ferrarimartina longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT dimarcolorenza longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT pivettialessandra longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT paduanostefania longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT vecchichiara longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT bernabucciveronica longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT critellirosinamaria longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT lasagnisimone longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT demariamonica longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT venturellidonatella longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT pecorarimonica longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT boarettogiorgia longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT serpinigiuliafregni longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT romagnolidante longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT mantovaniroberto longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT ceccherelligiovannibattista longtermsarscov2antibodyseroprevalenceinblooddonorsitaly AT villaerica longtermsarscov2antibodyseroprevalenceinblooddonorsitaly |